Embody vs Trimi Health: Which GLP-1 Provider Is Better?
Short answer: Embody scores higher on our rubric, 7.3/10 against 4.2/10. Full reasoning, pricing and the cases where the other one wins are below.
Embody beats Trimi Health overall, scoring 7.3/10 vs 4.2/10. Published pricing is not a like-for-like monthly comparison: Embody is from $69/mo; Trimi Health is $175/mo month-to-month. Choose Embody for people who want the oral tirzepatide gum, or who are comfortable selecting a 4-, 12-, 24- or 52-week plan for an advertised glp-1 + gip rate from $129. Choose Trimi Health for cash-pay patients who want the cheapest flat-price compounded semaglutide we track ($99/mo on the annual plan) and will accept a weak trustpilot record plus no-pro-rating cancellation terms in exchange.
A side-by-side look at Embody and Trimi Health to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Embody
#32 of 54Online weight-loss program that ships compounded GLP-1 medication to your door. Modern Metabolic Medicine, Inc. runs the storefront and OpenLoop Health supplies the clinical network on the current site. Embody now advertises compounded semaglutide from $79 and GLP-1 + GIP from $129; its FAQ says the chosen rate holds within a selected 4-, 12-, 24- or 52-week plan. Its standout is oral tirzepatide gum for people who do not want injections.
Visit EmbodyTrimi Health
#52 of 54Telehealth platform for compounded semaglutide and tirzepatide. Weekly injections in vial-and-syringe format only, no pens, no oral option. Pricing is flat across all doses, with the consult and overnight shipping included. Prescriptions route through the Arora Health medical group (Dr. Sean Arora MD, medical director) and are filled by VialsRx and GreenwichRx, the same backend that powers Telos RX. Founded May 2024 per the site's own schema markup; no legal entity suffix or street address is disclosed.
Visit Trimi Health| Feature | Embody | Trimi Health |
|---|---|---|
| Our Score | 7.3/10 | 4.2/10 |
| Headline Price | from $69/mo | $175/mo month-to-month |
| Medication Type | Compounded | Compounded |
| Insurance Accepted | No | No |
| Best For | People who want the oral tirzepatide gum, or who are comfortable selecting a 4-, 12-, 24- or 52-week plan for an advertised GLP-1 + GIP rate from $129 | Cash-pay patients who want the cheapest flat-price compounded semaglutide we track ($99/mo on the annual plan) and will accept a weak Trustpilot record plus no-pro-rating cancellation terms in exchange |
| Watch out for | Runs two sibling storefronts most shoppers will never connect to it: SnagRx (snagrx.com) and RodeoMeds (rodeomeds.com) are the same legal entity, Modern Metabolic Medicine, Inc. SnagRx still advertises a separate $69/$119 promotion; Embody now advertises $79/$129 under its own plan menu. Neither site tells shoppers they share an operator. See our [SnagRx review](/reviews/snagrx) | Trustpilot FELL from 4.6 earlier in 2026 to 3.4 across 71 reviews, ranking #62 of 70 in its category, recurring complaints cite account closures and withheld refunds |
| Ranking | #32 | #52 |
| Get started | Visit Embody | Visit Trimi Health |
Pros & Cons Compared
Embody
Pros
- +Oral tirzepatide gum is rare. Real option for needle-phobic users. (How well it absorbs vs the FDA-approved injection isn't published.)
- +Advertised injection floors of $79 for semaglutide and $129 for GLP-1 + GIP, verified August 14, 2026. The FAQ says the selected rate holds within the chosen plan.
- +Four plan lengths are disclosed (4, 12, 24 and 52 weeks), giving shoppers a shorter-term option as well as longer-plan pricing.
- +100% money-back guarantee in writing: if you follow the program and don't see results in 6 months, they say they'll make it right.
- +Replies to every negative Trustpilot review, usually within 24 hours.
Cons
- −Runs two sibling storefronts most shoppers will never connect to it: SnagRx (snagrx.com) and RodeoMeds (rodeomeds.com) are the same legal entity, Modern Metabolic Medicine, Inc. SnagRx still advertises a separate $69/$119 promotion; Embody now advertises $79/$129 under its own plan menu. Neither site tells shoppers they share an operator. See our [SnagRx review](/reviews/snagrx)
- −The $79/$129 figures are advertised floors tied to a selected 4-, 12-, 24- or 52-week plan, not a verified no-commitment month-to-month rate. Confirm the plan length and total before payment.
- −Trustpilot rating is 3.8 / 5 across 5,305 reviews, verified August 14, 2026. Price and billing remain recurring complaint themes, although many reviews describe earlier pricing structures.
- −Embody names four pharmacy partners: RedRock Pharmacy, Health Warehouse, Precision Compounding and Triad Rx. It does not state whether each prescription is filled through a 503A pharmacy or a 503B outsourcing facility. Triad Rx received a 2019 FDA warning letter for sterile-production violations; FDA closed it out in May 2023.
- −No HIPAA disclosure on their site (HIPAA is the federal law protecting your medical info, most telehealth providers publish a statement confirming they follow it).
- −Compounded medications only, no brand-name Wegovy, Zepbound, Mounjaro, or Ozempic available.
- −If you stop treatment and come back, Embody's doctors will likely restart you at the lowest dose (2.5mg). It's their safety policy; raise your dose history at signup, the prescriber makes the final call.
Trimi Health
Pros
- +$99/mo compounded semaglutide on the annual plan (billed $1,188 once yearly) is among the cheapest flat recurring rates we track; tirzepatide annual is $125/mo ($1,500 yearly)
- +Flat pricing across all doses, your monthly price does not rise as your dose titrates up
- +Consult and overnight shipping included in the plan price, no add-on fees; HSA/FSA accepted, Klarna and Affirm financing available
- +Named medical director, Dr. Sean Arora MD of the Arora Health medical group, most compounded-only platforms name no one
- +Compounding pharmacies named: VialsRx (TX license #35264, site-claimed) and GreenwichRx, most competitors do not name theirs
- +Available in all 50 states plus DC per trytrimi.com/states
- +6-month money-back weight-loss promise published (conditions apply, read them before counting on it)
Cons
- −Trustpilot FELL from 4.6 earlier in 2026 to 3.4 across 71 reviews, ranking #62 of 70 in its category, recurring complaints cite account closures and withheld refunds
- −Once a prescription is signed, payments are final, no pro-rating, cancelling an annual plan mid-year forfeits the remainder. Full refund is available only BEFORE the prescription is signed
- −No legal entity disclosed, the site identifies only 'Trimi Health' with no LLC/Inc suffix and no street address (New York appears only in the site's schema markup)
- −Vial-and-syringe format only, no autoinjector pens, no oral option, no brand-name medications
- −LegitScript certification claimed but we could not verify it against LegitScript's registry
- −Mandatory arbitration clause in the terms
- −Retatrutide and orforglipron are listed as 'Preparing', roadmap items, not available today, do not enroll expecting them
- −Shares its medical group (Arora Health) and pharmacy (VialsRx) with Telos RX, a white-label backend relationship neither brand discloses on its own site
Our Verdict
Embody edges out Trimi Health with a score of 7.3/10 vs 4.2/10. Published pricing is not a like-for-like monthly comparison: Embody is from $69/mo; Trimi Health is $175/mo month-to-month.
Read Full Reviews
Related comparisons
More head-to-head comparisons involving Embody and Trimi Health.
- Embody vs Noom Med$79 first month, then $199/mo
- Embody vs GobyMedsfrom $99/mo
- Embody vs WeightWatchers (Sequence)$74/mo membership + medication
- Trimi Health vs Galafrom $149/mo
- Trimi Health vs Ro$149/mo membership + medication
- Trimi Health vs Henry Medsfrom $199/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Our pick of these two: Embody · 7.3/10